Li, Z. ., Ju, X. ., Lee, K. ., Clarke, C. ., Hsu, J. ., Abadir, E. ., … Program, G. C. I. N. T. (2018). CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma. Haematologica. https://doi.org/10.3324/haematol.2017.178384 (Original work published 2018)
Grant. Program
First name:
Grant.
Middle name:
Cancer Institute NSW Translationl
Last name:
Program